Literature DB >> 10231093

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein.

M Hansson1, J Ringdahl, A Robert, U Power, L Goetsch, T N Nguyen, M Uhlén, S Ståhl, P A Nygren.   

Abstract

Using phage-display technology, a novel binding protein (Z-affibody) showing selective binding to the RSV (Long strain) G protein was selected from a combinatorial library of a small alpha-helical protein domain (Z), derived from staphylococcal protein A (SPA). Biopanning of the Z-library against a recombinant fusion protein comprising amino acids 130-230 of the G protein from RSV-subgroup A, resulted in the selection of a Z-affibody (Z(RSV1)) which showed G protein specific binding. Using biosensor technology, the affinity (K(D)) between Z(RSV1) and the recombinant protein was determined to be in the micromolar range (10(-6) M). Interestingly, the Z(RSV1) affibody was demonstrated to also recognize the partially (54%) homologous G protein of RSV subgroup B with similar affinity. Using different recombinant RSV G protein derived fragments, the binding was found to be dependent on the presence of the cysteinyl residues proposed to be involved in the formation of an intramolecular disulfide-constrained loop structure, indicating a conformation-dependent binding. Results from epitope mapping studies, employing a panel of monoclonal antibodies directed to different RSV G protein subfragments, suggest that the Z(RSV1) affibody binding site is located within the region of amino acids 164-186 of the G protein. This region contains a 13 amino acid residue sequence which is totally conserved between subgroups A and B of RSV and extends into the cystein loop region (amino acids 173-186). The potential use of the RSV G protein-specific Z(RSV1) affibody in diagnostic and therapeutic applications is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231093     DOI: 10.1016/s1380-2933(98)00026-8

Source DB:  PubMed          Journal:  Immunotechnology        ISSN: 1380-2933


  13 in total

1.  TEM-1 beta-lactamase as a scaffold for protein recognition and assay.

Authors:  Daniel Legendre; Bénédicte Vucic; Vincent Hougardy; Anne-Lise Girboux; Christophe Henrioul; Julien Van Haute; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

2.  An affibody in complex with a target protein: structure and coupled folding.

Authors:  Elisabet Wahlberg; Christofer Lendel; Magnus Helgstrand; Peter Allard; Vildan Dincbas-Renqvist; Anders Hedqvist; Helena Berglund; Per-Ake Nygren; Torleif Härd
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

Review 3.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

4.  A Gradient of Sitewise Diversity Promotes Evolutionary Fitness for Binder Discovery in a Three-Helix Bundle Protein Scaffold.

Authors:  Daniel R Woldring; Patrick V Holec; Lawrence A Stern; Yang Du; Benjamin J Hackel
Journal:  Biochemistry       Date:  2017-03-09       Impact factor: 3.162

5.  Staphylococcal surface display of immunoglobulin A (IgA)- and IgE-specific in vitro-selected binding proteins (affibodies) based on Staphylococcus aureus protein A.

Authors:  E Gunneriusson; P Samuelson; J Ringdahl; H Grönlund; P A Nygren; S Ståhl
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

6.  Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer.

Authors:  Richard H Kimura; Robert Teed; Benjamin J Hackel; Marybeth A Pysz; Courtney Z Chuang; Ataya Sathirachinda; Jürgen K Willmann; Sanjiv S Gambhir
Journal:  Clin Cancer Res       Date:  2011-12-15       Impact factor: 12.531

7.  Biophysical characterization of Z(SPA-1)--a phage-display selected binder to protein A.

Authors:  Christofer Lendel; Vildan Dincbas-Renqvist; Alexander Flores; Elisabet Wahlberg; Jakob Dogan; Per-Ake Nygren; Torleif Härd
Journal:  Protein Sci       Date:  2004-07-06       Impact factor: 6.725

Review 8.  Biofunctionalized targeted nanoparticles for therapeutic applications.

Authors:  Andrew Z Wang; Frank Gu; Liangfang Zhang; Juliana M Chan; Aleksander Radovic-Moreno; Mariam R Shaikh; Omid C Farokhzad
Journal:  Expert Opin Biol Ther       Date:  2008-08       Impact factor: 4.388

9.  Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate.

Authors:  Bahman Moradipoodeh; Mostafa Jamalan; Majid Zeinali; Masood Fereidoonnezhad; Ghorban Mohammadzadeh
Journal:  Mol Biol Rep       Date:  2020-09-14       Impact factor: 2.316

10.  Fluorescence-activated cell sorting of specific affibody-displaying staphylococci.

Authors:  Henrik Wernérus; Patrik Samuelson; Stefan Ståhl
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.